where is retatrutide approved produces up to 30.3% weight loss in Phase 3 trial RETATRUTIDE (RETA) – Research Peptide

The GLP-1 receptor activation promotes insulin secretion in a glucose-dependent manner, slows gastric emptying, and reduces appetite through central nervous system pathways

How GLP-1s Offer Real-World Heart Protection The evidence that GLP1-s reduce the risk of heart attack and stroke comes from large cardiovascular outcomes trials designed to measure what researchers call MACE, major adverse cardiovascular events

Skin feels softer, looks better, kinda like a little treat every day

Microdosing GLP-1s, like Ozempic or Wegovy, has exploded in popularity over the past year with some TikTok creators saying it has completely changed their lives. Some are microdosing as a way to maintain weight, while others are using it as a cost-cutting method